161 related articles for article (PubMed ID: 34476527)
1. On the probability of lymph node negativity in pN0-staged prostate cancer-a theoretically derived rule of thumb for adjuvant needs.
Paulsen F; Bedke J; Wegener D; Marzec J; Martus P; Nann D; Stenzl A; Zips D; Müller AC
Strahlenther Onkol; 2022 Aug; 198(8):690-699. PubMed ID: 34476527
[TBL] [Abstract][Full Text] [Related]
2. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A
Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
[TBL] [Abstract][Full Text] [Related]
3. Primary lymph-node staging with
Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
[TBL] [Abstract][Full Text] [Related]
4. Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal disease.
Tan KS; Hsu M; Adusumilli PS
Lung Cancer; 2022 Dec; 174():60-66. PubMed ID: 36334358
[TBL] [Abstract][Full Text] [Related]
5. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
[TBL] [Abstract][Full Text] [Related]
6. [11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy.
Schumacher MC; Radecka E; Hellström M; Jacobsson H; Sundin A
Scand J Urol; 2015 Feb; 49(1):35-42. PubMed ID: 25001948
[TBL] [Abstract][Full Text] [Related]
7. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC).
Xu L; Tian J; Liu Y; Li C
J Magn Reson Imaging; 2014 Jul; 40(1):200-5. PubMed ID: 24923480
[TBL] [Abstract][Full Text] [Related]
9. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
J Nucl Med; 2003 Mar; 44(3):331-5. PubMed ID: 12620996
[TBL] [Abstract][Full Text] [Related]
10. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A
Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770
[TBL] [Abstract][Full Text] [Related]
11. Pelvic lymph node dissection in prostate cancer.
Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
[TBL] [Abstract][Full Text] [Related]
12. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
[TBL] [Abstract][Full Text] [Related]
13. Predicting pelvic lymph node involvement in current-era prostate cancer.
Rahman S; Cosmatos H; Dave G; Williams S; Tome M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):906-10. PubMed ID: 21300478
[TBL] [Abstract][Full Text] [Related]
14. Linking surgical specimen length and examined lymph nodes in colorectal cancer patients.
Stracci F; Bianconi F; Leite S; Liso A; La Rosa F; Lancellotta V; van de Velde CJ; Aristei C
Eur J Surg Oncol; 2016 Feb; 42(2):260-5. PubMed ID: 26723169
[TBL] [Abstract][Full Text] [Related]
15. Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes: comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases.
Martínez-Piñeiro L; Rios E; Martínez-Gomariz M; Pastor T; de Cabo M; Picazo ML; Palacios J; Perona R
Eur Urol; 2003 Apr; 43(4):342-50. PubMed ID: 12667714
[TBL] [Abstract][Full Text] [Related]
16. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?
Bader P; Burkhard FC; Markwalder R; Studer UE
J Urol; 2002 Aug; 168(2):514-8; discussion 518. PubMed ID: 12131300
[TBL] [Abstract][Full Text] [Related]
17. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
18. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
19. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
Heidenreich A; Ohlmann CH
Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
[TBL] [Abstract][Full Text] [Related]
20. Predicting the patient at low risk for lymph node metastasis with localized prostate cancer: an analysis of four statistical models.
Spevack L; Killion LT; West JC; Rooker GM; Brewer EA; Cuddy PG
Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):543-7. PubMed ID: 8621276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
